Mechanical Hemodynamic Support

  • Scott A. Schartel


The mainstay of treatment for patients with inadequate hemodynamic performance is maintaining appropriate intravascular volume (preload), vascular tone (afterload), and myocardial pump function (contractility), most commonly accomplished by volume administration or diuretic therapy, pharmacologic manipulation of the vascular tone with vasodilators or vasopressors, and inotropic agents. When these measures result in an inadequate response in hemodynamic performance, mechanical circulatory support may be indicated. This chapter discusses the major mechanical circulatory support techniques currently available for use in critically ill patients, including intraaortic balloon counterpulsation (IABC) therapy, ventricular-assist devices (VADs), and extracorporeal membrane oxygenation (ECMO).


Cardiogenic Shock Balloon Catheter Limb Ischemia Mechanical Circulatory Support Intraaortic Balloon 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Aroesty JM, Shawl FA. Circulatory assist devices. In: Bain DS, Grossman W (eds) Cardiac Catheterization, Angiography, and Intervention, 5th Ed. Baltimore: Williams Wilkins, 1996: 421–462.Google Scholar
  2. Barnette MG, Swartz MT, Petersen GJ, et al. Vascular complications from intraaortic balloons: risk analysis. J Vasc Surg 1994; 19: 8189.Google Scholar
  3. Conrad SA, Rycus PT. Extracorporeal life support 1997. ASAIO J 1998: 848–852.Google Scholar
  4. El-Banayosy A, Posival H, Minami K, et al. Seven years experience with the centrifugal pump in patients with cardiogenic shock. Thorac Cardiovasc Surg 1999; 43: 347–351.CrossRefGoogle Scholar
  5. Farrar DJ, Hill JD, Pennington DG, et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the Thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1997; 113: 202–209.PubMedCrossRefGoogle Scholar
  6. Guyton RA, Schonberger JPAM, Everts PAM, et al. Postcardiotomy shock: clinical evaluation of the BVS 5000 biventricular support system. Ann Thorac Surg 1993; 56: 346–356.PubMedCrossRefGoogle Scholar
  7. Hazelrigg SR, Auer JE, Seifert PE. Experience in 100 transthoracic balloon pumps. Ann Thorac Surg 1992; 54: 528–532.PubMedCrossRefGoogle Scholar
  8. Jett GK. Abiomed BVS 5000: experience and potential advantages. Arm Thorac Surg 1996; 61: 301–304.CrossRefGoogle Scholar
  9. Körfer R, El-Banayosy A, Posival H, et al. Mechanical circulatory support with the Thoratec assist device in patients with postcardiotomy cardiogenic shock. Ann Thorac Surg 1996; 61: 314316.Google Scholar
  10. Makhoul RG, Cole CW, McCann RL. Vascular complications of the intra-aortic balloon pump: an analysis of 436 patients. Am Surg 1993; 59: 564–568.PubMedGoogle Scholar
  11. Murali S. Mechanical circulatory support with the Novacor LVAS: world-wide clinical results. Thorac Cardiovasc Surg 1999; 47 (supplement): 321–325.PubMedCrossRefGoogle Scholar
  12. Naunheim KS, Swartz MT, Pennington DG, et al. Intraaortic balloon pumping in patients requiring cardiac operations: risk analysis and long-term follow-up. J Thorac Cardiovasc Surg 1992; 104: 1654 1661.Google Scholar
  13. Patel JJ, Kopisyansky C, Boston B, et al. Prospective evaluation of complications associated with percutaneous intraaortic balloon counterpulsation. Am J Cardiol 1995; 76: 1205–1207.PubMedCrossRefGoogle Scholar
  14. Poirier VL. The HeartMate left ventricular assist system: worldwide clinical results. Eur J Cardio-Thorac Surg 1997: S39 — S44.Google Scholar
  15. Schmid C, Weynd M, Nabavi DG, et al. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg 1998; 65: 1703–1710.PubMedCrossRefGoogle Scholar
  16. Slater JP, Rose EA, Levin HR, et al. Lower thromboembolic risk without anticoagulation using advance-design left ventricular assist devices. Ann Thorac Surg 1996; 62: 1321–1327.PubMedCrossRefGoogle Scholar
  17. Stavridis GT, O’Riordan JB. Paraplegia as a result of intra-aortic balloon counterpulsation. J Cardiovasc Surg 1995; 36: 177–179.Google Scholar
  18. Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomizedevaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1997; 29: 1459–1467.PubMedCrossRefGoogle Scholar
  19. Suchyta MR, Clemmer TP, Orme JF, et al. Increased survival of ARDS patients with severe hypoxemia (ECMO criteria). Chest 1991; 99: 951–955.PubMedCrossRefGoogle Scholar
  20. Vonderheide RH, Thadhani R, Kuter DJ. Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med 1998; 105: 27–32.PubMedCrossRefGoogle Scholar
  21. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. JAMA 1979; 242 (20): 2193–2196.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Scott A. Schartel

There are no affiliations available

Personalised recommendations